Search Results 591-600 of 17341 for SC
The purpose of this study is to assess the pharmacodynamics (PD) of HM15211 after administration of multiple subcutaneous (SC) doses compared to placebo on ...
The primary objective of this study is to determine whether treatment with daratumumab administered subcutaneously (SC) prolongs progression-free survival ...
... SC, Buckles S, Bumgardner M, Gallagher C, Fee-Schroeder K, Nicholas NR, Powers ML, Ragab AK, Richardson DM, Stai A, Wilson J, Pacyna JE, Olson JE, Sutton EJ ...
Nuss as he is a Mayo surgical fellowship graduate,” Dr. Potter says. In January 2017, Sara and Scarlett traveled from their home in South Carolina to Mayo ...
ResidencyMedical University of South Carolina. 2017. Medical SchoolUniversity of Arkansas for Medical Sciences. 2013. Undergraduate StudiesHendrix College. Show ...
Interferon beta-1a injection is used to treat the relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting ...
... SC, Abouassaly R. Contemporary management of advanced prostate cancer: an evolving landscape. Clin Adv Hematol Oncol. 2021 Feb; 19 (2):108-118. View PubMed ...
Malaisrie SC, Szeto WY, Halas M, Girardi LN, Coselli JS, Sundt TM 3rd, Chen EP, Fischbein MP, Gleason TG, Okita Y, Ouzounian M, Patel HJ, Roselli EE ...
Alumni spotlight. Dr. Ilyas Aleem. Ilyas Aleem, M.D., M.Sc.
Scottsdale/Phoenix, Arizona: 17-007127. NCT ID: NCT03080883. Sponsor Protocol Number: ACCRU-SC-1601. About this study. This randomized phase III trial studies ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!